Search Results - "Rajdev L"

Durable Marked Response of Unresectable Esophageal Squamous Cell Carcinoma After Radiotherapy Alone Followed by Combination Immunotherapy.

Authors: Watanabe, Yasuhiro Miyamoto, Shin′ichi Asano, Yoichi et al.

Source: Case Reports in Oncological Medicine. 2/27/2026, Vol. 2026, p1-5. 5p.

Clinical Validation of the Belay Ascent™ Test to Report on Chromosomal Arm-Level Aneuploidy and Gene-Level Copy Number Variants in Cerebrospinal Fluid Using Low-Pass Whole-Genome Sequencing.

Authors: Nie, Qian Schilter, Kala F. Larson, Alexandra et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1277. 20p.

Comprehensive Genomic Profiling for Precision Oncology: Analytical Validation and Clinical Utility in Solid Tumors.

Authors: Mondal, Ashis K. Vashisht, Ashutosh Vashisht, Vishakha et al.

Source: Diagnostics (2075-4418). Apr2026, Vol. 16 Issue 7, p1087. 15p.

People Living with HIV Eligibility in Canadian Cancer Clinical Trials.

Authors: Comelles, Maria F. Perez-Patrigeon, Santiago Senneker, Tessa et al.

Source: Current Oncology. Feb2026, Vol. 31 Issue 2, p102. 12p.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024.

Authors: Leigh, Jennifer Ahmed, Arwa Aubin, Francine et al.

Source: Current Oncology. Mar2025, Vol. 32 Issue 3, p175. 17p.

Trends in Cancer Diagnoses Among People Living with HIV: A 20-Year Retrospective Study from a Tertiary Center in Thailand.

Authors: Wonglhow, Jirapat Chaiwiriyawong, Supakorn Sunpaweravong, Patrapim et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p22. 12p.

Outcomes of Anal Cancer Patients with Inflammatory Bowel Disease Treated with Curative Chemoradiotherapy: A Systematic Review of Current Evidence.

Authors: Royal-Preyra, Benjamin Boucher, Melanie

Source: Current Oncology. Dec2025, Vol. 32 Issue 12, p693. 18p.

STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma.

Authors: Fulgenzi, Claudia A. M. Dalla Pria, Alessia Leone, Alberto Giovanni et al.

Source: BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-8. 8p.

Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy.

Authors: Shaikh, Fyza Y. Lee, Seoho White, James R. et al.

Source: Cancers. Nov2024, Vol. 16 Issue 21, p3644. 13p.

Deciphering the Heterogeneity of Cancer-Associated Fibroblasts in Prostate Cancer: From Stromal Biology to Clinical Translation.

Authors: Truong, Ho Trong Tan Kwon, Whi-An Woo, Hyeong Jung et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1600. 28p.

HIV-1 controllers possess a unique CD8⁺ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers.

Authors: Jones, Amber D. Capriotti, Zachary Santos, Erin et al.

Source: PLoS ONE. 8/28/2025, Vol. 20 Issue 8, p1-24. 24p.

Fighting HER2 in Gastric Cancer: Current Approaches and Future Landscapes.

Authors: Ratti, Margherita Citterio, Chiara Orlandi, Elena et al.

Source: International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 15, p7285. 18p.

Treatment of Pancreatic Cancer Using Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Combination with Anticancer Chemotherapeutic Drug.

Authors: Yonemura, Hiroki Kuwatani, Masaki Nakajima, Kohei et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1584. 16p.

GPX3 suppresses gallbladder cancer progression by modulating redox balance, glycolysis, and anti-tumor immunity.

Authors: Ma, Zuyi Sun, Jia Wu, Xin et al.

Source: Oncogenesis. 4/2/2026, Vol. 15 Issue 1, p1-18. 18p.

Neoadjuvant Therapy for Esophageal Cancer.

Authors: Samadzadeh Tabrizi, Nika Marthy, Andrew Fabian, Thomas

Source: Cancers. Mar2026, Vol. 18 Issue 5, p750. 13p.

Targeting the Tumour Microenvironment in Pancreatic Cancer: From Stromal Reprogramming to Emerging Therapeutics.

Authors: Mittal, Kartik Rathi, Neha Tripathi, Devika et al.

Source: Future Pharmacology. Mar2026, Vol. 6 Issue 1, p12. 29p.

International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.

Authors: Samuel R Knight SR Adams R et al.

Corporate Authors: Samuel R Knight SR Adams R et al.

Source: EClinicalMedicine [EClinicalMedicine] 2024 Dec 05; Vol. 78, pp. 102939. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Silent lungs, aching knee: Isolated knee pain as the initial presentation of lung adenocarcinoma.

Authors: Woo, Fui Bee Chew, Shing Wei Huan, Nai-Chien et al.

Source: University of Toronto Medical Journal. Jun2026, Vol. 103 Issue 2, p74-76. 3p.

Combination Therapy of Pyrotinib and Metronomic Vinorelbine in HER2+ Advanced Breast Cancer after Trastuzumab Failure (PROVE): A Prospective Phase 2 Study.

Authors: Hao, Chunfang Wang, Xu Shi, Yehui et al.

Source: Cancer Research & Treatment. Apr2025, Vol. 57 Issue 2, p434-442. 9p.

Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.

Authors: Fougner, Vincent Urup, Thomas Poulsen, Hans Skovgaard et al.

Source: Neuro-Oncology Practice. Feb2025, Vol. 12 Issue 1, p34-44. 11p.